Detalles de la búsqueda
1.
Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c , weight and hypoglycaemic event incidence.
Diabet Med;
35(5): 557-566, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29377320
2.
The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus.
Diabet Med;
32(7): 890-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817050
3.
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective.
BMC Health Serv Res;
15: 496, 2015 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26541516
4.
Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model.
Diabetes Obes Metab;
12(5): 431-6, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20415691
5.
A population model evaluating the costs and benefits associated with different oral treatment strategies in people with type 2 diabetes.
Diabetes Obes Metab;
12(7): 623-30, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20590737
6.
Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model.
Value Health;
17(7): A546, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27201770
7.
Comparing the Event Prediction Capability of the Ukpds68 and Hong Kong Diabetes Risk Equations within A Type 2 Diabetes Simulation Model.
Value Health;
17(7): A729-30, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202601
8.
Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea.
Curr Med Res Opin;
32(5): 807-16, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700585
9.
Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.
Pharmacoeconomics;
33(2): 149-61, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344660
10.
Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.
Aliment Pharmacol Ther;
16(8): 1469-80, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12182747
11.
The market for pharmaceuticals.
Dev Health Econ Public Policy;
7: 187-208, 1998.
Artículo
en Inglés
| MEDLINE | ID: mdl-10538829
Resultados
1 -
11
de 11
1
Próxima >
>>